Skin & Sarcoma Division
Make an appointment
Cutaneous Malignancy Program
The Cutaneous Malignancy Program at the John Theurer Cancer Center is a multidisciplinary approach to the prevention, treatment and management of cutaneous malignancies, including all stages of malignant melanoma, squamous cell carcinoma, basal-cell carcinoma, and other cutaneous malignancies.
This program brings together specialists, technology and advanced treatments for superior outcomes with malignant melanoma, squamous cell carcinoma, basal-cell carcinoma, and other cutaneous malignancies. Our team will develop a customized treatment plan to battle the disease and its physical, emotional, and social side effects.
Our team is focused on evaluating the safety and efficacy of new chemotherapeutic agents, new treatment methods, medical and surgical technologies, imaging studies, protocols for treatments, and medical devices. Most recently, we were involved in the landmark study that led to the FDA's fast track and approval of YERVOY (ipilimumab), a breakthrough treatment for metastatic melanoma and our clinicians had access to the treatment immediately upon the approval.
We invite you to call on our experts to provide a consultation or manage your case during any stage of the disease. Our multidisciplinary team consists of leading experts in:
- Medical Oncology
- Mohs Surgery
- Oncologic Surgery
- Plastic & Reconstructive Surgery
- Radiation Oncology
- Research & Innovation
The Sarcoma Division comprises a specialized team of professionals who are dedicated to preventing, diagnosing, treating, and managing all types of sarcomas (cancers of the bone, soft tissue, muscles, joints, and connective tissues). They use a variety of advanced methods including new cellular medicine techniques, limb-sparing surgery, cancer-fighting vaccines, radiofrequency ablation, and induction chemotherapy.
The sarcoma medicine team brings together experts in medical hematology/oncology, orthopedic surgery, radiation oncology, dermatology, radiology, and nursing. This specialized approach to treating skin cancers and sarcomas provides patients with the exact type of services they need to battle the disease and its physical, emotional, and social side effects.
Andrew Pecora, M.D.,F.A.C.P,C.P.E.
Chief, Cutaneous Malignancy Program and Co-Chief, Sarcoma
▪ Dr. Pecora is internationally-recognized for immunology clinical and research expertise. His cutaneous malignancy research has been published in several medical journals, including New England Journal of Medicine.
▪ Offers innovative approaches including cellular medicine techniques, cancer-fighting vaccines, and induction chemotherapy.
▪ Involved in the landmark study that led to the FDA's fast track and approval of YERVOY (ipilimumab), a breakthrough treatment for metastatic melanoma. Read full bio.
Oncologic Surgery - Cutaneous Malignancy Program
Donald A. McCain, M.D., P.H.D., F.A.C.S.
Vice Chairman and Chief, Surgical Oncology and Chief, Surgical Oncology, Cutaneous Malignancy Program
▪ Dr. McCain leads one of the largest surgical melanoma practices in New Jersey, conducting more lymphatic cases than any surgeon in the state.
▪ Surgical expertise for complex regions, including head and neck, axilla and, groin.
▪ Evaluate microscopic spread of melanoma to lymph nodes basin with a Tc99 sulfur colloid mapping agent.
▪ Advanced surgical techniques, such as primary resection of the melanoma with appropriate margins around the tumor to minimize recurrence, careful dissection of the lymph nodes, resection of deeper lymph nodes or internal organs of spread, and complex recurrence. Read full bio.
Oncologic Surgery - Sarcoma
James Wittig, M.D.
Co-Chief, Sarcoma Division
▪ Dr. Wittig is one of only a handful of orthopedic oncologists in the tri-state area who is experienced in performing complicated limb-sparing surgeries and other orthopedic cancer techniques, such as epineural analgesia, radiofrequency ablation, and cryosurgery
▪ Dr. Wittig trained in vascular surgery and plastic surgery as well as orthopedic oncology. Primary orthopedic cancers are rare. Dr. Wittig treats these tumors regularly, which makes him highly experienced and qualified to remove them and manage the patient's ongoing cancer care.
▪ At the John Theurer Cancer Center, 95 percent of patients with orthopedic malignancies do not have to lose an arm or leg to cancer or a benign tumor if they undergo the limb-sparing surgery. Read full bio.
Anthony Ingenito, M.D.
Chairman, Radiation Oncology
▪ Full-range of radiation oncology services and technologies.
▪ Most experienced TomoTherapy radiation center in New Jersey.
▪ First cancer center in New Jersey to acquire state-of the-art TrueBeam radiotherapy system.
▪ Offers RapidArc radiotherapy technology on TrueBeam, minimizing exposure to surrounding normal tissues in dramatically shorter treatment times.
▪ Above ground radiation facility. Read full bio.
Dermatology and Mohs Surgery
Robin Ashinoff, M.D.
Chief Dermatologic, Mohs and Laser Surgery
▪ Dr. Ashinoff is a nationally-recognized dermatologic surgeon with more than 20 years of experience. Her research has been extensively published in medical journals including Journal of Dermatology and Dermatological Surgery.
▪ Specialized care for the treatment of malignant and benign skin lesions with extensive expertise in Mohs micrographic surgery, a specialized procedure that has the highest cure rate of all surgical treatments for basal cell and squamos cell carcinoma.
▪ Extensive expertise in dermoscopy to improve early diagnosis of melanoma.
David de Vinck, D.O.
Pathologist, Anatomic Pathology and Dermatopathology
▪ One of the only cancer centers in New Jersey with a dermapathology specialist on the staff.
▪ Complete pathology team with a full range of pathology and comprehensive diagnostic testing.
▪ Full service lab offering standard processing, immunohistochemistry, and FISH testing.
Plastic and Reconstructive Surgery
Richard Winters, M.D., F.A.C.S.
Vice Chairman, Plastic and Reconstructive Surgery
▪ Dr. Winters has over 15 years of clinical and surgical expertise, including plastic surgery training at Cornell,New York hospital and additional training in complex microsurgery.
▪ Extensive experience in facial reconstruction following excision of skin cancers.
▪ Cancer resection and treatment is not limited by complexity of reconstruction required.
Advanced Practice Nurse/Clinician